{"id":"https://openalex.org/W2198196477","doi":"https://doi.org/10.1634/theoncologist.2015-0165","title":"Oral Azacitidine (CC-486) for the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia","display_name":"Oral Azacitidine (CC-486) for the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia","publication_year":2015,"publication_date":"2015-10-13","ids":{"openalex":"https://openalex.org/W2198196477","doi":"https://doi.org/10.1634/theoncologist.2015-0165","mag":"2198196477","pmid":"https://pubmed.ncbi.nlm.nih.gov/26463870","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4679081"},"language":"en","primary_location":{"id":"doi:10.1634/theoncologist.2015-0165","doi":"https://doi.org/10.1634/theoncologist.2015-0165","is_oa":true,"landing_page_url":"https://doi.org/10.1634/theoncologist.2015-0165","pdf_url":"https://theoncologist.onlinelibrary.wiley.com/doi/pdfdirect/10.1634/theoncologist.2015-0165","source":{"id":"https://openalex.org/S15523509","display_name":"The Oncologist","issn_l":"1083-7159","issn":["1083-7159","1549-490X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316295","host_organization_name":"AlphaMed Press","host_organization_lineage":["https://openalex.org/P4310316295"],"host_organization_lineage_names":["AlphaMed Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Oncologist","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://theoncologist.onlinelibrary.wiley.com/doi/pdfdirect/10.1634/theoncologist.2015-0165","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042492175","display_name":"Christopher Ramin Cogle","orcid":"https://orcid.org/0000-0001-5422-6863","observed_orcids":["https://orcid.org/0000-0001-5422-6863"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Christopher R. Cogle","raw_affiliation_strings":["Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, Florida, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, Florida, USA","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074629157","display_name":"Bart Lee Scott","orcid":"https://orcid.org/0000-0001-9620-7839","observed_orcids":["https://orcid.org/0000-0001-9620-7839"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bart L. Scott","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center, Seattle, Washington, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center, Seattle, Washington, USA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081735534","display_name":"Thomas E. Boyd","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas Boyd","raw_affiliation_strings":["North Star Lodge Cancer Center, Yakima, Washington, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"North Star Lodge Cancer Center, Yakima, Washington, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061026876","display_name":"Guillermo Garcia\u2010Manero","orcid":"https://orcid.org/0000-0002-3631-2482","observed_orcids":["https://orcid.org/0000-0002-3631-2482"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guillermo Garcia-Manero","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5042492175"],"corresponding_institution_ids":["https://openalex.org/I33213144"],"apc_list":{"value":3852,"currency":"USD","value_usd":3852},"apc_paid":null,"fwci":0.6979,"has_fulltext":true,"cited_by_count":46,"citation_normalized_percentile":{"value":0.57108817,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"20","issue":"12","first_page":"1404","last_page":"1412"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oral-azacitidine","display_name":"oral azacitidine","score":0.9509999752044678},{"id":"https://openalex.org/keywords/cc-486","display_name":"CC-486","score":0.9980000257492065},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9940000176429749},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":1.0},{"id":"https://openalex.org/keywords/epigenetic-modifiers","display_name":"epigenetic regulators","score":0.9240000247955322},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.7450000047683716},{"id":"https://openalex.org/keywords/stem-cell-transplantation","display_name":"stem cell transplantation","score":0.6129999756813049},{"id":"https://openalex.org/keywords/treatment-tolerability","display_name":"treatment tolerability","score":0.460999995470047}],"concepts":[{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.9557583332061768},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8647655248641968},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.7325257062911987},{"id":"https://openalex.org/C2780235182","wikidata":"https://www.wikidata.org/wiki/Q1181878","display_name":"Decitabine","level":5,"score":0.731751024723053},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.631068229675293},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6150792837142944},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5599250793457031},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5285899639129639},{"id":"https://openalex.org/C2776012956","wikidata":"https://www.wikidata.org/wiki/Q17125294","display_name":"Hypomethylating agent","level":5,"score":0.464485228061676},{"id":"https://openalex.org/C2780240888","wikidata":"https://www.wikidata.org/wiki/Q6052586","display_name":"International Prognostic Scoring System","level":4,"score":0.4635554850101471},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.45628342032432556},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.3755805492401123},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.3008913993835449},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.11471819877624512},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001374","descriptor_name":"Azacitidine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001374","descriptor_name":"Azacitidine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D001374","descriptor_name":"Azacitidine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1634/theoncologist.2015-0165","doi":"https://doi.org/10.1634/theoncologist.2015-0165","is_oa":true,"landing_page_url":"https://doi.org/10.1634/theoncologist.2015-0165","pdf_url":"https://theoncologist.onlinelibrary.wiley.com/doi/pdfdirect/10.1634/theoncologist.2015-0165","source":{"id":"https://openalex.org/S15523509","display_name":"The Oncologist","issn_l":"1083-7159","issn":["1083-7159","1549-490X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316295","host_organization_name":"AlphaMed Press","host_organization_lineage":["https://openalex.org/P4310316295"],"host_organization_lineage_names":["AlphaMed Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Oncologist","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4051276","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4679081","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4679081","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4679081","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncologist","raw_type":"Text"},{"id":"pmid:26463870","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26463870","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The oncologist","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1634/theoncologist.2015-0165","doi":"https://doi.org/10.1634/theoncologist.2015-0165","is_oa":true,"landing_page_url":"https://doi.org/10.1634/theoncologist.2015-0165","pdf_url":"https://theoncologist.onlinelibrary.wiley.com/doi/pdfdirect/10.1634/theoncologist.2015-0165","source":{"id":"https://openalex.org/S15523509","display_name":"The Oncologist","issn_l":"1083-7159","issn":["1083-7159","1549-490X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316295","host_organization_name":"AlphaMed Press","host_organization_lineage":["https://openalex.org/P4310316295"],"host_organization_lineage_names":["AlphaMed Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Oncologist","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320309086","display_name":"Celgene","ror":"https://ror.org/0527yg379"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2198196477.pdf","grobid_xml":"https://content.openalex.org/works/W2198196477.grobid-xml"},"referenced_works_count":88,"referenced_works":["https://openalex.org/W6398642","https://openalex.org/W187238933","https://openalex.org/W215808923","https://openalex.org/W1498319790","https://openalex.org/W1513084177","https://openalex.org/W1513468396","https://openalex.org/W1517594014","https://openalex.org/W1600365609","https://openalex.org/W1863755384","https://openalex.org/W1883939012","https://openalex.org/W1893997768","https://openalex.org/W1964809738","https://openalex.org/W1967008538","https://openalex.org/W1971273543","https://openalex.org/W1973018894","https://openalex.org/W1974020470","https://openalex.org/W1975522050","https://openalex.org/W1979144446","https://openalex.org/W1983624670","https://openalex.org/W1988778085","https://openalex.org/W1988907854","https://openalex.org/W1993236149","https://openalex.org/W1997998180","https://openalex.org/W1998002264","https://openalex.org/W2000252768","https://openalex.org/W2005181042","https://openalex.org/W2005969440","https://openalex.org/W2009650262","https://openalex.org/W2010318973","https://openalex.org/W2012753533","https://openalex.org/W2013657344","https://openalex.org/W2015809796","https://openalex.org/W2018074634","https://openalex.org/W2026134786","https://openalex.org/W2027950772","https://openalex.org/W2040393829","https://openalex.org/W2041191257","https://openalex.org/W2052822682","https://openalex.org/W2079254093","https://openalex.org/W2080270409","https://openalex.org/W2081895311","https://openalex.org/W2090915775","https://openalex.org/W2099056818","https://openalex.org/W2106584820","https://openalex.org/W2106833395","https://openalex.org/W2113950481","https://openalex.org/W2116453057","https://openalex.org/W2116858301","https://openalex.org/W2117674210","https://openalex.org/W2118771330","https://openalex.org/W2121710010","https://openalex.org/W2127851369","https://openalex.org/W2129510594","https://openalex.org/W2131593570","https://openalex.org/W2133650635","https://openalex.org/W2134702041","https://openalex.org/W2145337538","https://openalex.org/W2147083172","https://openalex.org/W2148428508","https://openalex.org/W2154220906","https://openalex.org/W2157287007","https://openalex.org/W2157783208","https://openalex.org/W2159066232","https://openalex.org/W2159507916","https://openalex.org/W2161234867","https://openalex.org/W2167485228","https://openalex.org/W2169476614","https://openalex.org/W2171665947","https://openalex.org/W2172277773","https://openalex.org/W2210429310","https://openalex.org/W2265091238","https://openalex.org/W2326726820","https://openalex.org/W2414179423","https://openalex.org/W2469723064","https://openalex.org/W2510630609","https://openalex.org/W2552210007","https://openalex.org/W2559398122","https://openalex.org/W2568528737","https://openalex.org/W2597036492","https://openalex.org/W2979345711","https://openalex.org/W2979538951","https://openalex.org/W2979729045","https://openalex.org/W3135020720","https://openalex.org/W3143094649","https://openalex.org/W4247972768","https://openalex.org/W4256176606","https://openalex.org/W4298071613","https://openalex.org/W6768972366"],"related_works":["https://openalex.org/W3204185128","https://openalex.org/W2979345711","https://openalex.org/W2573724996","https://openalex.org/W1759279428","https://openalex.org/W2884246240","https://openalex.org/W6967790389","https://openalex.org/W2265091238","https://openalex.org/W2148428508","https://openalex.org/W2029385426","https://openalex.org/W1975111516"],"abstract_inverted_index":{"The":[0,59],"myelodysplastic":[1],"syndromes":[2],"(MDS)":[3],"comprise":[4],"a":[5,119],"heterogeneous":[6],"group":[7],"of":[8,21,45,75,79,88,104,107,126,169,177,228,242,246],"clonal":[9],"myeloid":[10,25,46],"malignancies":[11],"characterized":[12,41],"by":[13,42],"multilineage":[14,94],"cytopenias,":[15],"recurrent":[16],"cytogenetic":[17],"abnormalities,":[18],"and":[19,52,63,81,93,139,141,158,164,206,233,235,240],"risk":[20,191],"progression":[22],"to":[23,38,97],"acute":[24],"leukemia":[26],"(AML).":[27],"AML,":[28],"which":[29],"can":[30],"occur":[31],"de":[32],"novo":[33],"as":[34,36,184,193,207],"well":[35],"secondary":[37],"MDS,":[39,192],"is":[40,67],"malignant":[43],"clones":[44],"lineage":[47],"in":[48,69,82,118,160,187,231],"the":[49,70,73,86,98,226,237,243],"bone":[50],"marrow":[51],"peripheral":[53],"blood,":[54],"with":[55,90,109,111,148,162,189,198,212],"dissemination":[56],"into":[57],"tissues.":[58],"cytidine":[60],"nucleoside":[61],"analog":[62],"epigenetic":[64],"modifier":[65],"azacitidine":[66,105,127,150,171,230],"approved":[68],"U.S.":[71],"for":[72,85,136,196,202,210,239],"treatment":[74,87,106],"all":[76],"French-American-British":[77],"subtypes":[78],"MDS":[80,163,213,232],"many":[83],"countries":[84],"AML":[89,110,199,215,234],"20%-30%":[91],"blasts":[92,113],"dysplasia":[95],"according":[96],"World":[99],"Health":[100],"Organization":[101],"classification.":[102],"Benefits":[103],"patients":[108,161,188,197,211],">30%":[112],"have":[114,152],"also":[115],"been":[116],"shown":[117,153],"recent":[120],"phase":[121],"III":[122],"trial.":[123],"Oral":[124],"administration":[125],"may":[128],"enhance":[129],"patient":[130],"convenience,":[131],"eliminate":[132],"injection-site":[133],"reactions,":[134],"allow":[135],"alternative":[137],"dosing":[138,167],"scheduling,":[140],"enable":[142],"long-term":[143],"treatment.":[144],"Phase":[145],"I":[146],"studies":[147],"oral":[149,170,247],"(CC-486)":[151],"biological":[154],"activity,":[155],"clinical":[156,223,244],"responses,":[157],"tolerability":[159],"AML.":[165],"Extended":[166],"schedules":[168],"(for":[172],"14":[173],"or":[174,214],"21":[175],"days":[176],"28-day":[178],"cycles)":[179],"are":[180],"currently":[181],"under":[182],"investigation":[183],"frontline":[185],"therapy":[186,195,209],"lower":[190],"maintenance":[194,208],"not":[200],"eligible":[201],"stem":[203,217],"cell":[204,218],"transplant,":[205],"following":[216],"transplant.":[219],"This":[220],"review":[221],"presents":[222],"data":[224],"supporting":[225],"use":[227],"injectable":[229],"examines":[236],"rationale":[238],"results":[241],"development":[245],"azacitidine.":[248]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":6}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}